Gardasil User Fee Date Extended By A Week
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck's BLA submission date for its human papillomavirus vaccine Gardasil has been delayed by an "initial cursory review" by FDA, the company said
You may also be interested in...
Gardasil Granted Priority Review
Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7
Gardasil Granted Priority Review
Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7
Merck Takes A Shot At A June Approval For HPV Vaccine Gardasil
The firm requests a priority review for the human papillomavirus vaccine’s BLA, submitted Dec. 1.